Please assess the completion status of the following clinical trial:

Trial Title: Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of acute myeloid leukemia (AML) by bone marrow biopsy~  * Newly diagnosed~* Must have adequate dendritic cells and AML blasts isolated from bone marrow and/or peripheral blood~* No clinical evidence of CNS leukemia~PATIENT CHARACTERISTICS:~Age~* 18 and over~Performance status~* Not specified~Life expectancy~* Not specified~Hematopoietic~* Not specified~Hepatic~* Not specified~Renal~* Not specified~Other~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~* HIV negative~* No clinically significant autoimmune disease~* No other active malignancy except nonmelanoma skin cancer~PRIOR CONCURRENT THERAPY:~Biologic therapy~* More than 3 months since prior immunotherapy~Chemotherapy~* Not specified~Endocrine therapy~* Not specified~Radiotherapy~* Not specified~Surgery~* Not specified

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).